Vanguard Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79.2M Buy
959,529
+6,092
+0.6% +$540K ﹤0.01% 1662
2026
Q2
$91.5M Buy
953,437
+41,379
+5% +$4.24M ﹤0.01% 1595
2026
Q1
$100M Buy
+912,058
New +$86.9M ﹤0.01% 1469

Other funds holding LMAT

Vanguard Capital Management's LMAT Position: Q3 2026 in Review

Vanguard Capital Management increased its LeMaitre Vascular (LMAT) stake by 0.64% in Q3 2026, buying an estimated $540K and bringing the position to 959,529 shares worth $79.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Vanguard Capital Management first reported a position in LMAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $100M in Q1 2026. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Vanguard Capital Management held 959,529 shares of LeMaitre Vascular worth $79.2M as of Q3 2026.
  • Vanguard Capital Management bought 6,092 LeMaitre Vascular shares in Q3 2026, an estimated $540K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1662 holding.
  • Vanguard Capital Management first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's LeMaitre Vascular position peaked at $100M in Q1 2026.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.